Novacyt (NCYT) Competitors GBX 38.50 -1.95 (-4.82%) As of 05/22/2025 12:42 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock NCYT vs. IUG, CREO, POLX, IHC, AVO, RUA, MHC, SUN, BELL, and DEMGShould you be buying Novacyt stock or one of its competitors? The main competitors of Novacyt include Intelligent Ultrasound Group (IUG), Creo Medical Group (CREO), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), MyHealthChecked (MHC), Surgical Innovations Group (SUN), Belluscura (BELL), and Deltex Medical Group (DEMG). These companies are all part of the "medical devices" industry. Novacyt vs. Intelligent Ultrasound Group Creo Medical Group Polarean Imaging Inspiration Healthcare Group Advanced Oncotherapy RUA Life Sciences MyHealthChecked Surgical Innovations Group Belluscura Deltex Medical Group Novacyt (LON:NCYT) and Intelligent Ultrasound Group (LON:IUG) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, community ranking, risk, institutional ownership, earnings, dividends and analyst recommendations. Which has higher earnings & valuation, NCYT or IUG? Intelligent Ultrasound Group has lower revenue, but higher earnings than Novacyt. Novacyt is trading at a lower price-to-earnings ratio than Intelligent Ultrasound Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNovacyt£18.12M1.47-£36.80M-£54.44-0.71Intelligent Ultrasound Group£6.57M0.00-£2.27M-£0.68N/A Does the MarketBeat Community prefer NCYT or IUG? Novacyt received 36 more outperform votes than Intelligent Ultrasound Group when rated by MarketBeat users. CompanyUnderperformOutperformNovacytOutperform Votes3658.06% Underperform Votes2641.94% Intelligent Ultrasound GroupN/AN/A Do institutionals & insiders hold more shares of NCYT or IUG? 0.1% of Novacyt shares are owned by institutional investors. Comparatively, 75.5% of Intelligent Ultrasound Group shares are owned by institutional investors. 3.1% of Novacyt shares are owned by insiders. Comparatively, 12.8% of Intelligent Ultrasound Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more risk and volatility, NCYT or IUG? Novacyt has a beta of -1.86, indicating that its stock price is 286% less volatile than the S&P 500. Comparatively, Intelligent Ultrasound Group has a beta of 0.38, indicating that its stock price is 62% less volatile than the S&P 500. Is NCYT or IUG more profitable? Intelligent Ultrasound Group has a net margin of -34.56% compared to Novacyt's net margin of -203.06%. Intelligent Ultrasound Group's return on equity of -37.71% beat Novacyt's return on equity.Company Net Margins Return on Equity Return on Assets Novacyt-203.06% -47.73% -27.98% Intelligent Ultrasound Group -34.56%-37.71%-13.51% Does the media refer more to NCYT or IUG? In the previous week, Novacyt's average media sentiment score of 0.00 equaled Intelligent Ultrasound Group'saverage media sentiment score. Company Overall Sentiment Novacyt Neutral Intelligent Ultrasound Group Neutral SummaryIntelligent Ultrasound Group beats Novacyt on 8 of the 11 factors compared between the two stocks. Get Novacyt News Delivered to You Automatically Sign up to receive the latest news and ratings for NCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NCYT vs. The Competition Export to ExcelMetricNovacytMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£26.60M£3.32B£5.33B£2.64BDividend YieldN/A2.44%5.21%5.05%P/E Ratio-0.7170.1626.80134.69Price / Sales1.47106.29397.78224,245.30Price / Cash0.5815.9938.2528.03Price / Book0.393.596.773.80Net Income-£36.80M£126.02M£3.23B£5.88B7 Day Performance-0.52%3.65%0.48%0.43%1 Month Performance-3.91%6.71%9.13%21.47%1 Year Performance-43.40%-3.33%18.58%129.56% Novacyt Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NCYTNovacytN/AGBX 38.50-4.8%N/A-36.9%£26.60M£18.12M-0.71120IUGIntelligent Ultrasound GroupN/AN/AN/AN/A£42.76M£6.57M-18.9165CREOCreo Medical GroupN/AGBX 10.17-0.8%N/A-66.3%£41.12M£33.87M-1.61279Earnings ReportPOLXPolarean ImagingN/AGBX 1.23+2.5%N/A-19.0%£18.05M£5.21M-0.3228Gap UpHigh Trading VolumeIHCInspiration Healthcare GroupN/AGBX 17.50-2.8%N/A+23.5%£15.16M£42.87M-1.20224AVOAdvanced OncotherapyN/AN/AN/AN/A£9.50MN/A-25.003,900Gap DownRUARUA Life SciencesN/AGBX 11.53-3.9%N/A-14.4%£7.15M£4.05M-2.6948Positive NewsGap DownMHCMyHealthCheckedN/AGBX 13+4.0%N/A+11.1%£6.77M£9.43M-6.4816Gap UpSUNSurgical Innovations GroupN/AGBX 0.68+3.8%N/A+34.0%£6.30M£12.54M-21.1180Gap UpBELLBelluscuraN/AGBX 1-12.5%N/A-93.9%£2.52M£2.87M-0.1124High Trading VolumeDEMGDeltex Medical GroupN/AN/AN/AN/A£187,000.00£1.76M-0.1537Gap UpHigh Trading Volume Related Companies and Tools Related Companies Intelligent Ultrasound Group Alternatives Creo Medical Group Alternatives Polarean Imaging Alternatives Inspiration Healthcare Group Alternatives Advanced Oncotherapy Alternatives RUA Life Sciences Alternatives MyHealthChecked Alternatives Surgical Innovations Group Alternatives Belluscura Alternatives Deltex Medical Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:NCYT) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novacyt S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novacyt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NCYT Stock Free NCYT Stock Alerts